Premium
Subtype classification of functional constipation in children: polyethylene glycol versus lactulose
Author(s) -
Bae Sun Hwan,
Kim Mok Ryeon
Publication year - 2020
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1111/ped.14235
Subject(s) - medicine , constipation , lactulose , gastroenterology , fecal incontinence , defecation , functional constipation , peg ratio , polyethylene glycol , transit time , feces , paleontology , finance , chemical engineering , transport engineering , engineering , economics , biology
Background This study aimed to evaluate the usefulness, from a therapeutic perspective, of classifying the subtypes of functional childhood constipation using a colon transit time (CTT) test. Methods A total of 190 children were enrolled in this study, which was based on data collected from a defecation diary, a CTT test, and medical records. Results Polyethylene glycol (PEG) 4000 was prescribed in 51.1% ( N = 47/92) of normal transit type constipation cases (NT) and 91.8% ( N = 90/98) of abnormal transit type constipation cases ( P < 0.001). In terms of the subtype of CTT test, PEG 4000 was prescribed in 51.1% ( N = 47/92) of NT cases, 96.2% ( N = 25/26) of outlet obstruction type cases (OT), and 90.3% ( N = 65/72) of slow transit type cases (ST) ( P < 0.001). Polyethylene glycol 4000 was administered in 97.2% ( N = 35/36) of the fecal incontinence group and 66.2% ( N = 102/154) of the non‐fecal incontinence group ( P < 0.001). In the non‐fecal incontinence group, PEG 4000 was prescribed in 47.3% ( N = 40/84) of NT cases, 94.4% ( N = 17/18) of OT cases, and 86.5% ( N = 45/52) of ST cases ( P < 0.001). In the fecal incontinence group, PEG 4000 was prescribed in 87.5% ( N = 7/8) of NT cases, 100% ( N = 8/8) of OT cases, and 100% ( N = 20/20) of ST cases ( P = 0.165). Conclusions Subtype classification of functional constipation based on the CTT test provides important information for the initial choice of drugs in children.